Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients.
Journal of Allergy and Clinical Immunology（2020）
摘要
This is the first study that objectively compares the molecular cutaneous improvement with different treatments in AD and may facilitate personalized medicine by identifying the best treatments for individual phenotypes, based on immune/barrier profiles.
更多查看译文
关键词
ASN002,Atopic dermatitis,corticosteroids,crisaborole,cyclosporine,dupilumab,fezakinumab,narrow-band ultraviolet type B,precision medicine,ustekinumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要